{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:39:16Z","timestamp":1790354356960,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA022453"],"award-info":[{"award-number":["P30CA022453"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10552-022-01648-w","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:02:57Z","timestamp":1668243777000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center"],"prefix":"10.1007","volume":"34","author":[{"given":"Nadine","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen S.","family":"Purrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Tatineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Assad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancie","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-6761","authenticated-orcid":false,"given":"Michael S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"1648_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7\u201334","journal-title":"CA Cancer J Clin"},{"key":"1648_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","volume":"41","author":"P Economopoulou","year":"2015","unstructured":"Economopoulou P, Dimitriadis G, Psyrri A (2015) Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev 41:1\u20138","journal-title":"Cancer Treat Rev"},{"key":"1648_CR3","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.1251827","volume":"343","author":"FJ Couch","year":"2014","unstructured":"Couch FJ, Nathanson KL, Offit K (2014) Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 343:1466\u20131470","journal-title":"Science"},{"key":"1648_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416","journal-title":"JAMA"},{"key":"1648_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamasurg.2017.0552","volume":"152","author":"OM Valencia","year":"2017","unstructured":"Valencia OM, Samuel SE, Viscusi RK, Riall TS, Neumayer LA, Aziz H (2017) The role of genetic testing in patients with breast cancer: a review. JAMA Surg 152:589\u2013594","journal-title":"JAMA Surg"},{"key":"1648_CR6","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA 298:2869\u20132876","journal-title":"JAMA"},{"key":"1648_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jmg.2005.034744","volume":"43","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Silber A, Matloff E, Chung J, Lannin D (2006) Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet 43:133\u2013137","journal-title":"J Med Genet"},{"key":"1648_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cge.12315","volume":"86","author":"JM Eggington","year":"2014","unstructured":"Eggington JM, Bowles KR, Moyes K et al (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86:229\u2013237","journal-title":"Clin Genet"},{"key":"1648_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222\u20132233","journal-title":"Cancer"},{"issue":"6","key":"1648_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/annonc\/mdm234","volume":"18","author":"R Ferla","year":"2007","unstructured":"Ferla R, Calo V, Cascio S et al (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(6):93\u201398","journal-title":"Ann Oncol"},{"key":"1648_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10549-014-3218-x","volume":"149","author":"E Rosenthal","year":"2015","unstructured":"Rosenthal E, Moyes K, Arnell C, Evans B, Wenstrup RJ (2015) Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry. Breast Cancer Res Treat 149:223\u2013227","journal-title":"Breast Cancer Res Treat"},{"key":"1648_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1096-185","volume":"14","author":"BB Roa","year":"1996","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185\u2013187","journal-title":"Nat Genet"},{"key":"1648_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937\u2013948","journal-title":"Nat Rev Cancer"},{"key":"1648_CR14","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0959-8049(01)00299-4","volume":"37","author":"P Moller","year":"2001","unstructured":"Moller P, Heimdal K, Apold J et al (2001) Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer 37:2428\u20132434","journal-title":"Eur J Cancer"},{"key":"1648_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.ejhg.5200529","volume":"8","author":"L Sarantaus","year":"2000","unstructured":"Sarantaus L, Huusko P, Eerola H et al (2000) Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet 8:757\u2013763","journal-title":"Eur J Hum Genet"},{"key":"1648_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/B:FAME.0000026819.44213.df","volume":"3","author":"D Muller","year":"2004","unstructured":"Muller D, Bonaiti-Pellie C, Abecassis J, Stoppa-Lyonnet D, Fricker JP (2004) BRCA1 testing in breast and\/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect. Fam Cancer 3:15\u201320","journal-title":"Fam Cancer"},{"key":"1648_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.ejhg.5200704","volume":"9","author":"A Bergman","year":"2001","unstructured":"Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9:787\u2013793","journal-title":"Eur J Hum Genet"},{"key":"1648_CR18","unstructured":"CancerGene with BRCAPRO, MMRpro, PancPRO, and MelaPRO."},{"key":"1648_CR19","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry Jr","year":"2002","unstructured":"Berry DA Jr, ESI, Gudbjartsson DF, et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701\u20132712","journal-title":"J Clin Oncol"},{"key":"1648_CR20","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16:2417\u20132425","journal-title":"J Clin Oncol"},{"key":"1648_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480\u20131490","journal-title":"J Clin Oncol"},{"key":"1648_CR22","unstructured":"National Comprehensive Cancer Network Genetic\/familial high-risk assessment: breast and ovarian. Version 2.2016."},{"key":"1648_CR23","unstructured":"LLC -PG. PROGENY."},{"key":"1648_CR24","unstructured":"R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/."},{"key":"1648_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"AW Kurian","year":"2010","unstructured":"Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22:72\u201378","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"15","key":"1648_CR26","doi-asserted-by":"publisher","first-page":"e13636","DOI":"10.1200\/JCO.2020.38.15_suppl.e13636","volume":"38","author":"JA Ciuro","year":"2020","unstructured":"Ciuro JA, Ahsan S, Beyer A, Jackson N (2020) Healthcare disparities and the demand for expanding hereditary breast cancer screening guidelines in African Americans. J Clin Oncol 38(15):e13636","journal-title":"J Clin Oncol"},{"key":"1648_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/humu.1136","volume":"17","author":"A Vega","year":"2001","unstructured":"Vega A, Campos B, Bressac-De-Paillerets B et al (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 17:520\u2013521","journal-title":"Hum Mutat"},{"key":"1648_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A et al (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the clinical cancer genetics community research network. J Clin Oncol 31:210\u2013216","journal-title":"J Clin Oncol"},{"key":"1648_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1634\/theoncologist.2014-0364","volume":"20","author":"NS El Saghir","year":"2015","unstructured":"El Saghir NS, Zgheib NK, Assi HA et al (2015) BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist 20:357\u2013364","journal-title":"Oncologist"},{"key":"1648_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavicius","year":"2010","unstructured":"Janavicius R (2010) Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1:397\u2013412","journal-title":"EPMA J"},{"key":"1648_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:353\u2013357","journal-title":"Gynecol Oncol"},{"key":"1648_CR32","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","volume":"294","author":"R Nanda","year":"2005","unstructured":"Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925\u20131933","journal-title":"JAMA"},{"key":"1648_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-019-0691-1","volume":"12","author":"NS Abul-Husn","year":"2019","unstructured":"Abul-Husn NS, Soper ER, Odgis JA et al (2019) Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med 12:2","journal-title":"Genome Med"},{"key":"1648_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/cge.12647","volume":"89","author":"A Finch","year":"2016","unstructured":"Finch A, Wang M, Fine A et al (2016) Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clin Genet 89:304\u2013311","journal-title":"Clin Genet"},{"key":"1648_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.maturitas.2013.09.012","volume":"77","author":"M-KM Tea","year":"2014","unstructured":"Tea M-KM, Kroiss R, Muhr D et al (2014) Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer. Maturitas 77:68\u201372","journal-title":"Maturitas"},{"key":"1648_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13053-017-0085-6","volume":"16","author":"C Heramb","year":"2018","unstructured":"Heramb C, Wangensteen T, Grindedal EM et al (2018) BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway. Hered Cancer Clin Pract 16:3","journal-title":"Hered Cancer Clin Pract"},{"key":"1648_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13053-016-0046-5","volume":"14","author":"P Wojcik","year":"2016","unstructured":"Wojcik P, Jasiowka M, Strycharz E et al (2016) Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hered Cancer Clin Pract 14:5","journal-title":"Hered Cancer Clin Pract"},{"key":"1648_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","volume":"151","author":"E Kang","year":"2015","unstructured":"Kang E, Seong M-W, Park SK et al (2015) The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat 151:157\u2013168","journal-title":"Breast Cancer Res Treat"},{"key":"1648_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ygyno.2018.02.014","volume":"149","author":"DA Barrington","year":"2018","unstructured":"Barrington DA, Champion ML, Boitano TKL et al (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337\u2013340","journal-title":"Gynecol Oncol"},{"key":"1648_CR40","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1002\/cncr.29645","volume":"121","author":"T Pal","year":"2015","unstructured":"Pal T, Bonner D, Cragun D et al (2015) A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer 121:4173\u20134180","journal-title":"Cancer"},{"key":"1648_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-014-3195-0","volume":"149","author":"JE Churpek","year":"2015","unstructured":"Churpek JE, Walsh T, Zheng Y et al (2015) Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat 149:31\u201339","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1648_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/cancers10110419","volume":"10","author":"HJ Diaz-Zabala","year":"2018","unstructured":"Diaz-Zabala HJ, Ortiz AP, Garland L et al (2018) A recurrent BRCA2 mutation explains the majority of hereditary breast and ovarian cancer syndrome cases in puerto rico. Cancers 10(11):419","journal-title":"Cancers"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-022-01648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:36:08Z","timestamp":1674639368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-022-01648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1007\/s10552-022-01648-w","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board at Karmanos Cancer Institute (IRB number: 111818M1E). This study does not involve human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. This study does not involve human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This study does not involve human subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}